The House Ways and Means Committee today held a hearing on the Department of Health and Human Services’ fiscal year 2019 budget request, at which HHS Secretary Alex Azar testified. The non-binding budget request proposes hundreds of billions of dollars in reductions to Medicare and Medicaid over 10 years, as well as a number of provisions related to drug pricing, opioids and other health-related issues. In his opening remarks, Chairman Kevin Brady (R-TX) said the committee has developed “consensus solutions” on health care and is “eager to work with the Trump administration to build on them wherever possible,” including “taking action to reduce the cost of prescription drugs.” Committee members also urged aggressive action to address the opioid crisis, and Democrats criticized the proposed cuts to Medicare and Medicaid. Ranking Member Richard Neal (D-MA) noted that the budget request “cuts more than $200 billion in payments to hospitals,” threatening additional hospital closures and the jobs they provide. Reps. Terri Sewell (D-AL) and Tom Rice (R-SC) also expressed concern about rural hospital closures. “We have consistently asked rural hospitals to do more with less,” Sewell said. “As a result, 83 rural hospitals have closed since 2010 across the country.”

Headline
The Centers for Medicare & Medicaid Services has begun collecting private payor rate data through its Fee-for-Service Data Collection System Clinical Lab…
Headline
Sens. Chuck Grassley, R-Iowa, and Michael Bennet, D-Colo., April 30 introduced the Rural Community Hospital Demonstration Reauthorization Act, legislation that…
Headline
The AHA April 29 urged House and Senate appropriations committee leaders to fund health care programs that have been successful in improving access to care for…
Headline
The AHA submitted a statement for the record to the House Ways and Means Committee for its April 28 hearing with health system CEOs.In the statement, the AHA…
Headline
The AHA again is asking the Health Resources and Services Administration to take action after Eli Lilly warned hospitals that they could lose access to…
Headline
The administration Apri 23 reached a most-favored-nation drug pricing agreement with Regeneron, the maker of the popular cholesterol medicine Praluent. This is…